Multiple sclerosis quietly rewires the immune system years before a person feels anything wrong. Scientists at UC San Francisco have now figured out how to see it coming—by reading the body's own warning signals in the bloodstream.
The discovery hinges on something elegant: when MS begins its attack on the brain, it leaves traces. Fragments of damaged myelin (the insulation around nerve fibers) enter the blood. Immune signaling proteins that guide the attack appear in measurable amounts. By analyzing over 5,000 proteins in blood samples from 134 people with MS, researchers mapped out the sequence of events that happens silently, years before diagnosis.
The Timeline Hidden in Your Blood
The story unfolds in stages. Seven years before someone gets diagnosed with MS, a protein called MOG (myelin oligodendrocyte glycoprotein) spikes in the bloodstream—a signal that the immune system has started attacking the myelin sheath. About a year later, another protein, neurofilament light chain, rises, indicating the nerve fibers themselves are now damaged. By this point, the central nervous system is already sustaining significant injury, but the person still feels completely fine.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxOne protein stood out as particularly important: IL-3. It acts like a beacon, drawing immune cells into the brain and spinal cord where they attack nerve tissue. Understanding its role during this silent window—when damage is happening but symptoms haven't yet appeared—could be the key to intervention.
The researchers made this discovery by studying blood samples collected decades earlier from U.S. military service members stored in the Department of Defense Serum Repository. Some of these people later developed MS, allowing scientists to look backward and see exactly what was happening in their blood years before diagnosis.
From Detection to Prevention
The team identified roughly 50 proteins that signal increased MS risk. They've filed a patent application for a diagnostic blood test based on the 21 most promising markers. "We now know that MS starts way earlier than the clinical onset, creating the real possibility that we could someday prevent MS—or at least use our understanding to protect people from further injury," said Ari Green, MD, chief of the Division of Neuroimmunology and Glial Biology at UCSF.
This shifts the entire conversation about MS from managing symptoms to potentially stopping the disease before it becomes symptomatic. For the roughly 2.3 million people worldwide living with MS, and the millions more who might develop it, that's not just a medical detail—it's the difference between a life-changing diagnosis and an early warning you can actually act on.
